03.06.2013 15:05 Uhr, Quelle: Wallstreet online

MorphoSys Signs Global License Agreement with GlaxoSmithKline for Anti-Inflammatory Program MOR103

MorphoSys AG / MorphoSys Signs Global License Agreement with GlaxoSmithKline for Anti-Inflammatory Program MOR103 . Processed and transmitted by Thomson Reuters ONE. The issuer is solely responsible for the content of this announcement. MorphoSys …

Weiterlesen bei Wallstreet online